255 related articles for article (PubMed ID: 19416168)
21. Relaxin activates multiple cAMP signaling pathway profiles in different target cells.
Halls ML; Hewitson TD; Moore XL; Du XJ; Bathgate RA; Summers RJ
Ann N Y Acad Sci; 2009 Apr; 1160():108-11. PubMed ID: 19416169
[TBL] [Abstract][Full Text] [Related]
22. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
Halls ML; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
[TBL] [Abstract][Full Text] [Related]
23. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
[TBL] [Abstract][Full Text] [Related]
24. Successful expression of a functional yeast G-protein-coupled receptor (Ste2) in mammalian cells.
Yin D; Gavi S; Shumay E; Duell K; Konopka JB; Malbon CC; Wang HY
Biochem Biophys Res Commun; 2005 Apr; 329(1):281-7. PubMed ID: 15721304
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
26. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
27. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
[TBL] [Abstract][Full Text] [Related]
28. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
29. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
[TBL] [Abstract][Full Text] [Related]
30. Endothelin A and endothelin B receptors differ in their ability to stimulate ERK1/2 activation.
Grantcharova E; Reusch HP; Beyermann M; Rosenthal W; Oksche A
Exp Biol Med (Maywood); 2006 Jun; 231(6):757-60. PubMed ID: 16740994
[TBL] [Abstract][Full Text] [Related]
31. The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3.
Zhang WJ; Wang XY; Guo YQ; Luo X; Gao XJ; Shao XX; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2014 May; 46(5):1393-402. PubMed ID: 24615237
[TBL] [Abstract][Full Text] [Related]
32. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL
J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598
[TBL] [Abstract][Full Text] [Related]
33. Structural properties of relaxin chimeras.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
[TBL] [Abstract][Full Text] [Related]
34. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses.
Sevillano N; Girón MD; Salido M; Vargas AM; Vilches J; Salto R
J Biochem; 2009 Jan; 145(1):21-30. PubMed ID: 18849572
[TBL] [Abstract][Full Text] [Related]
35. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function.
Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA
Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687
[TBL] [Abstract][Full Text] [Related]
36. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
37. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol modulates the binding properties of human relaxin family peptide receptor 3 with its ligands.
Wang JH; Hu MJ; Shao XX; Wei D; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2018 May; 646():24-30. PubMed ID: 29601823
[TBL] [Abstract][Full Text] [Related]
39. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
40. De novo design and synthesis of cyclic and linear peptides to mimic the binding cassette of human relaxin.
Hossain MA; Bathgate RA; Tregear G; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():16-9. PubMed ID: 19416152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
